From: Effect of lycopene against gastroesophageal reflux disease in experimental animals
Group | Treatment | Glutathione (mg %) | Superoxide dismutase (unit of SOD/ mg of protein) | Catalase (nM of H 2 O 2 /min /mg of protein) | Thiobarbituric acid reactive substances (nM of MDA/mg of protein) | Protein carbonyl (nM/ml) |
---|---|---|---|---|---|---|
Group-I | Sham control (Normal saline,3 ml/kg, p.o) | 4.71 ± 0.42*** | 110.39 ± 66.13 | 4.45 ± 0.40*** | 1.20 ± 0.06*** | 48.18 ± 1.82*** |
Group-II | Esophagitis control (Normal saline,3 ml/kg, p.o) | 3.69 ± 0.10 | 64.21 ± 31.76 | 2.58 ± 0.71 | 5.17 ± 0.01 | 162.12 ± 1.74 |
Group-III | Lycopene (50 mg/kg, p.o) | 4.78 ± 0.10*** | 71.70 ± 17.90 | 4.05 ± 0.78** | 3.28 ± 0.07*** | 129.39 ± 5.04*** |
Group-IV | Lycopene (100 mg/kg,p.o) | 4.02 ± 0.20c | 64.68 ± 15.09 | 4.10 ± 0.37*** | 3.03 ± 0.03***c | 112.50 ± 3.00***c |
Group-V | Pantoprazole (30 mg/kg, p.o) | 4.26 ± 0.05** | 67.89 ± 27.06 | 3.44 ± 0.38 | 2.84 ± 0.04*** | 98.26 ± 3.07*** |